Restricted accessReview articleFirst published online 2026
Efficacy of catheter lock solutions on central-line associated bloodstream infections (CLABSI) prevention: A systematic review and Bayesian network meta-analysis
Catheter lock solutions (CLs) are commonly used to reduce the risk of central line-associated bloodstream infections (CLABSI), but it remains uncertain which type is most beneficial for patients. This systematic review and Bayesian network meta-analysis synthesized available evidence by comparing different CLs directly and indirectly to prevent CLABSI and rank their effectiveness. A comprehensive search was performed across PubMed, Embase, Ovid, Scopus, Cochrane Library, and Google Scholar. After screening 2359 records by title and abstract and reviewing 374 full-text articles, 39 studies were included, covering seven CLs types. Bayesian network meta-analysis was conducted using STATA and ADDIS. Results showed that taurolidine-based (TCLs), ethanol-based (ECLs), gentamicin-based (GCLs), and EDTA-based (EDTA-CLs) solutions were more effective than saline or heparin in preventing CLABSI. According to the surface under the cumulative ranking curve (SUCRA), TCLs had the highest probability of reducing CLABSI (89.1%), followed by GCLs (82.6%) and EDTA-CLs (72.6%). In conclusion, this review underscores the clinical value of catheter lock solutions in CLABSI prevention, with strong evidence supporting the integration of TCLs into central venous catheter maintenance bundles due to their significant benefits.
MalekAERaadII. Preventing catheter-related infections in cancer patients: a review of current strategies. Expert Rev Anti Infect Ther2020; 18: 531–538.
HuKKLipskyBAVeenstraDL, et al. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control2004; 32: 142–146.
4.
KawamuraHTakahashiNTakahashiM, et al. The differences in microorganism growth on various dressings used to cover injection sites: inspection of the risk of catheter-related bloodstream infections caused by Gram-negative bacilli. Surg Today2014; 44: 2339–2344.
5.
MusuMFincoGMuraP, et al. Controlling catheter-related bloodstream infections through a multi-centre educational programme for intensive care units. J Hosp Infect2017; 97: 275–281.
6.
MaiHZhaoYSalernoS, et al. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials. Int Urol Nephrol2019; 51: 1019–1033.
7.
Vernon-RobertsALopezRNFramptonCM, et al. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr2022; 46: 1535–1552.
8.
van den BoschCJeremiasseBvan der BruggenJ, et al. The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis. J Hosp Infect2021; 123: 143–155.
9.
NorrisLBKablaouiFBrilhartMK, et al. Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients. Int J Antimicrob Agents2017; 50: 308–317.
10.
OliveiraCNasrABrindleM, et al. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics2012; 129: 318–329.
11.
ZhaoTLiuHHanJ.Ethanol lock is effective on reducing the incidence of tunneled catheter-related bloodstream infections in hemodialysis patients: a systematic review and meta-analysis. Int Urol Nephrol2018; 50: 1643–1652.
12.
HillJGarnerR.Efficacy of 4% tetrasodium ethylenediaminetetraacetic acid (T-EDTA) catheter lock solution in home parenteral nutrition patients: a quality improvement evaluation. J Vasc Access2021; 22: 533–539.
13.
HigginsJPWeltonNJ.Network meta-analysis: a norm for comparative effectiveness?Lancet2015; 386: 628–630.
14.
DangF-PLiH-JWangR-J, et al. Comparative efficacy of various antimicrobial lock solutions for preventing catheter-related bloodstream infections: a network meta-analysis of 9099 patients from 52 randomized controlled trials. Int J Infect Dis2019; 87: 154–165.
15.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021; 372:n71.
16.
National Healthcare Safety Network. Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection). CDC:NHSN.2022.
17.
KeladaASFosterTBGaglianoGC, et al. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients. Infect Control Hosp Epidemiol2023; 44: 377–383.
18.
HigginsJPAltmanDGGøtzschePC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ2011; 343: d5928.
19.
AbdelAElSaidTEl SaidH, et al. A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients. Clin Nephrol2018; 90: 341–349.
20.
BetjesMGvan AgterenM.Prevention of dialysis catheter-related sepsis with a citrate–taurolidine-containing lock solution. Nephrol Dial Transplant2004; 19: 1546–1551.
21.
BisselingTMWillemsMCVersleijenMW, et al. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr2010; 29: 464–468.
22.
BleyerAJMasonLRussellG, et al. A randomized, controlled trial of a new vascular catheter flush solution (minocycline–EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol2005; 26: 520–524.
23.
BroomJKKrishnasamyRHawleyCM, et al. A randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients—the HEALTHY–CATH trial. BMC Nephrol2012; 13: 1–9.
24.
CamposRPdo NascimentoMMChulaDC, et al. Minocycline–EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol2011; 22: 1939–1945.
25.
ChuH-PBrindJTomarR, et al. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock. J Pediatr Gastroenterol Nutr2012; 55: 403–407.
26.
ClarkJEGrahamNKleidonT, et al. Taurolidine–citrate line locks prevent recurrent central line-associated bloodstream infection in pediatric patients. Pediatr Infect Dis J2019; 38: e16–e18.
27.
CullisPSMcKeeRF.Taurolidine lock—experience from the West of Scotland. Clin Nutr2011; 30: 399–400.
28.
DograGKHersonHHutchisonB, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol2002; 13: 2133–2139.
29.
DümichenMSeegerKLodeH, et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J Hosp Infect2012; 80: 304–309.
30.
HandrupMMMøllerJKSchrøderH.Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatr Blood Cancer2013; 60: 1292–1298.
31.
HulshofECHanffLMOliemanJ, et al. Taurolidine in pediatric home parenteral nutrition patients. Pediatr Infect Dis J2017; 36: 233–235.
32.
JurewitschBJeejeebhoyKN.Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr2005; 24: 462–465.
33.
KanaaMWrightMJAkbaniH, et al. Cathasept line lock and microbial colonization of tunneled hemodialysis catheters: a multicenter randomized controlled trial. Am J Kidney Dis2015; 66: 1015–1023.
34.
LambeCPoissonCTalbotecC, et al. Strategies to reduce catheter-related bloodstream infections in pediatric patients receiving home parenteral nutrition: the efficacy of taurolidine–citrate prophylactic-locking. JPEN J Parenter Enteral Nutr2018; 42: 1017–1025.
35.
ŁyszkowskaMKowalewskiGSzymczakM, et al. Effects of prophylactic use of taurolidine–citrate lock on the number of catheter-related infections in children under 2 years of age undergoing surgery. J Hosp Infect2019; 103: 223–226.
36.
MacRaeJMDojcinovicIDjurdjevO, et al. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol2008; 3: 369–374.
37.
MezoffEAFeiLTrouttM, et al. Ethanol lock efficacy and associated complications in children with intestinal failure. JPEN J Parenter Enteral Nutr2016; 40: 815–819.
38.
MokhaJSDavidovicsZHSamelaK, et al. Effects of ethanol lock therapy on central line infections and mechanical problems in children with intestinal failure. JPEN J Parenter Enteral Nutr2017; 41: 625–631.
39.
MoranJSunSKhababaI, et al. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis2012; 59: 102–107.
40.
NoriUSManoharanAYeeJ, et al. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis2006; 48: 596–605.
41.
OlthofEDVersleijenMWHuisman-de WaalG, et al. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions. PLoS One2014; 9: e111216.
42.
PowerADuncanNSinghSK, et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis2009; 53: 1034–1041.
43.
RijndersBDiSciulloGJCsikyB, et al. Locking hemodialysis catheters with trimethoprim–ethanol–Ca-EDTA to prevent bloodstream infections: a randomized, evaluator-blinded clinical trial. Clin Infect Dis2019; 69: 130–136.
44.
SandersJPithieAGanlyP, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother2008; 62: 809–815.
45.
SaundersJNaghibiMLeachZ, et al. Taurolidine locks significantly reduce the incidence of catheter-related blood stream infections in high-risk patients on home parenteral nutrition. Eur J Clin Nutr2015; 69: 282–284.
46.
SchallomMEPrenticeDSonaC, et al. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Crit Care Med2012; 40: 1820–1826.
47.
SchootRAvan OmmenCHStijnenT, et al. Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: a randomised controlled multi-centre trial. Eur J Cancer2015; 51: 2031–2038.
48.
SimonAAmmannRAWiszniewskyG, et al. Taurolidine–citrate lock solution (TauroLock) significantly reduces CVAD-associated Gram positive infections in pediatric cancer patients. BMC Infect Dis2008; 8: 1–8.
49.
SlobbeLDoorduijnJKLugtenburgPJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One2010; 5: e10840.
50.
SolomonLRCheesbroughJSEbahL, et al. A randomized double-blind controlled trial of taurolidine–citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis2010; 55: 1060–1068.
51.
SouweineBLautretteAGrusonD, et al. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med2015; 191: 1024–1032.
52.
TouréALauverjatMPeraldiC, et al. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients. Clin Nutr2012; 31: 567–570.
53.
TriblerSBrandtCFPetersenAH, et al. Taurolidine–citrate–heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial. Am J Clin Nutr2017; 106: 839–848.
54.
WeijmerMCVan Den DorpelMAVan de VenPJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol2005; 16: 2769–2777.
55.
WinnickiWHerknerHLorenzM, et al. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney Int2018; 93: 753–760.
56.
WorthLJSlavinMHeathS, et al. Ethanol versus heparin locks for the prevention of central venous catheter-associated bloodstream infections: a randomized trial in adult haematology patients with Hickman devices. J Hosp Infect2014; 88: 48–51.
57.
WoutersYTheillaMSingerP, et al. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition. Aliment Pharmacol Ther2018; 48: 410–422.
58.
Centers for Disease Control and Prevention.Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). Device-associated Module BSI, 2017; 1–38.
59.
Correa BarcellosFPereira NunesBJorge ValleL, et al. Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial). Infection2017; 45: 139–145.
60.
MukherjeePKMohamedSChandraJ, et al. Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect Immun2006; 74: 3804–3816.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
